HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Western and Central Africa  /  COD

DR Congo

DR Congo appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. PEPFAR's results for the country are broken down by province and count only the sites PEPFAR supports. The assessment of national sources, country by country, is set out on the Methods page.

570,000
People living with HIV, 2025
WHO Global Health Observatory
71.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$24.2m
United States HIV disbursements, 2026
ForeignAssistance.gov
$217.0m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$100m$200m200220052008201120142017202020232026$217.0m$108.2m$108.5m$24.2m
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $2.8m $2.3m — —
2003 $15.6m $13.0m — $2.5m
2004 $13.9m $3.9m $3.2m $5.1m
2005 $33.2m $5.4m $18.1m $4.9m
2006 $32.0m $7.0m $13.1m $7.4m
2007 $36.8m $7.4m $14.2m $7.1m
2008 $61.1m $12.1m $37.3m $9.5m
2009 $27.6m $12.7m — $15.5m
2010 $72.0m $21.7m $35.9m $19.8m
2011 $64.8m $30.9m $25.6m $27.2m
2012 $117.4m $38.0m $73.6m $32.0m
2013 $97.7m $45.1m $45.8m $47.6m
2014 $58.1m $37.3m $14.7m $38.9m
2015 $76.7m $32.9m $39.3m $30.4m
2016 $114.4m $40.6m $69.2m $39.2m
2017 $145.0m $58.1m $84.6m $51.6m
2018 $67.5m $53.2m $11.5m $55.1m
2019 $33.7m $23.5m $6.7m $47.1m
2020 $107.0m $43.9m $61.5m $41.9m
2021 $155.6m $43.5m $111.0m $48.1m
2022 $130.2m $46.6m $83.1m $49.8m
2023 $159.2m $66.0m $92.4m $70.7m
2024 $217.0m $108.2m $108.5m $97.5m
2025 — — — $88.4m
2026 — — — $24.2m

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
0250k500k750k200020032006200920122015201820212024610,000440,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 710,000 560,000 870,000 —
2001 700,000 570,000 870,000 —
2002 700,000 560,000 860,000 —
2003 690,000 560,000 840,000 —
2004 680,000 550,000 820,000 —
2005 670,000 550,000 810,000 —
2006 660,000 550,000 800,000 —
2007 650,000 540,000 780,000 —
2008 630,000 540,000 760,000 —
2009 620,000 530,000 740,000 —
2010 610,000 530,000 730,000 44,000
2011 600,000 520,000 710,000 53,000
2012 590,000 510,000 700,000 66,000
2013 590,000 510,000 690,000 80,000
2014 580,000 500,000 680,000 100,000
2015 570,000 490,000 680,000 120,000
2016 570,000 490,000 670,000 160,000
2017 570,000 500,000 680,000 210,000
2018 580,000 500,000 680,000 210,000
2019 580,000 500,000 680,000 230,000
2020 580,000 500,000 690,000 310,000
2021 590,000 500,000 700,000 360,000
2022 600,000 500,000 710,000 400,000
2023 610,000 500,000 730,000 440,000
2024 610,000 500,000 750,000 440,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%25%50%75%2010201220142016201820202022202477.0%71.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 19.0% 7.0%
2011 21.0% 9.0%
2012 22.0% 11.0%
2013 25.0% 14.0%
2014 30.0% 18.0%
2015 35.0% 21.0%
2016 42.0% 27.0%
2017 49.0% 37.0%
2018 53.0% 36.0%
2019 57.0% 40.0%
2020 63.0% 53.0%
2021 69.0% 62.0%
2022 73.0% 67.0%
2023 77.0% 73.0%
2024 77.0% 71.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Data-quality flags on DR Congo

People receiving PrEP, 2021 (PEPFAR Panorama Spotlight). The value moved from 1,383 in 2020 to 7,774 in 2021, a change of more than threefold in a single year. The move from 1,383 to 7,774 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2020 and 2021 are not comparable. Check the figures by reporting organisation before reading a trend across 2020 and 2021.

Sources of the figures for DR Congo

4,041 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 801 29 2000–2024 aidsinfo.unaids.org 2026-10-20
Demographic and Health Surveys Survey 339 4 2007–2023 api.dhsprogram.com 2026-10-16
WHO Global Health Observatory Modelled estimate 243 12 2000–2025 ghoapi.azureedge.net 2026-10-12
PEPFAR results by province Programme record 210 7 2016–2025 data.pepfar.gov 2026-10-12
WHO Global Tuberculosis Programme Programme record 169 16 2000–2025 extranet.who.int 2026-10-16
PEPFAR results by funding agency and province Programme record 120 6 2018–2025 data.pepfar.gov 2026-10-12
ForeignAssistance.gov Expenditure account 111 5 2003–2026 foreignassistance.gov 2026-10-29
PEPFAR Panorama Spotlight Programme record 79 10 2018–2025 data.pepfar.gov 2026-10-12
WHO Global Health Expenditure Database Expenditure account 77 7 2013–2023 apps.who.int 2026-10-12
OECD Creditor Reporting System Expenditure account 66 3 2002–2024 sdmx.oecd.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 66 15 2013–2021 hivfinancial.unaids.org 2026-10-12
IATI, through d-portal Expenditure account 65 3 2000–2026 d-portal.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
PEPFAR results by funding agency Programme record 48 6 2018–2025 data.pepfar.gov 2026-10-12
PEPFAR testing by modality Programme record 48 6 2018–2025 data.pepfar.gov 2026-10-12
Global Fund Data Service Programme record 47 6 2017–2025 fetch.theglobalfund.org 2026-10-12
PEPFAR budgets and expenditure Expenditure account 40 8 2021–2025 data.pepfar.gov 2026-10-12
PEPFAR commodity procurement plans Expenditure account 28 4 2019–2025 data.pepfar.gov 2026-10-12
WHO HIV testing services dashboard Programme record 21 4 2019–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
PEPFAR operating-unit budgets Expenditure account 17 2 2007–2020 data.pepfar.gov 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 12 3 2015–2021 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
PEPFAR human resources for health inventory Expenditure account 3 3 2025 data.pepfar.gov 2026-10-12

Indicators held

107 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $500k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $5.7m (2025)
Country-reported HIV expenditure, all sources Financing USD 12 2012–2021 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $223.9m (2021)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $1.5m (2024)
Domestic public HIV expenditure Financing USD 10 2013–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $45.1m (2021)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $23.9m (2025)
Expected USAID funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $10.7m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $1.5m (2025)
External HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $193.5m (2023)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $217.0m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 27 2000–2026 IATI, through d-portal $14k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $340k (2026)
External HIV financing from the United States (ODA) Financing USD 47 2002–2026 ForeignAssistance.gov, OECD Creditor Reporting System $24.2m (2026)
Funding received for collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $500k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 165,747,565 (2026)
Global Fund HIV disbursements to the country Financing USD 49 2004–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $19.0m (2026)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $24.3m (2024)
Government HIV and STD spending as a share of government health spending Financing percent 11 2013–2023 WHO Global Health Expenditure Database 10.1% (2023)
Government HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $46.9m (2023)
HIV and STD spending as a share of all external health spending Financing percent 11 2013–2023 WHO Global Health Expenditure Database 21.1% (2023)
HIV and STD spending as a share of all health spending Financing percent 11 2013–2023 WHO Global Health Expenditure Database 9.8% (2023)
HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $243.2m (2023)
HIV spending on TB/HIV co-infection Financing USD 1 2021 UNAIDS Global AIDS Monitoring expenditure database $1.3m (2021)
HIV spending on critical enablers Financing USD 3 2016–2021 UNAIDS Global AIDS Monitoring expenditure database $948k (2021)
HIV spending on governance and sustainability Financing USD 4 2015–2021 UNAIDS Global AIDS Monitoring expenditure database $60.8m (2021)
HIV spending on prevention Financing USD 4 2015–2021 UNAIDS Global AIDS Monitoring expenditure database $6.4m (2021)
HIV spending on prevention of vertical transmission Financing USD 4 2015–2021 UNAIDS Global AIDS Monitoring expenditure database $1.1m (2021)
HIV spending on programmes for children and adolescents Financing USD 1 2021 UNAIDS Global AIDS Monitoring expenditure database $884k (2021)
HIV spending on treatment, care and support Financing USD 4 2015–2021 UNAIDS Global AIDS Monitoring expenditure database $152.5m (2021)
International HIV expenditure (country-reported) Financing USD 10 2013–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $163.9m (2021)
Other bilateral HIV expenditure (country-reported) Financing USD 6 2013–2021 UNAIDS Global AIDS Monitoring expenditure database $5.3m (2021)
Out-of-pocket HIV expenditure by households Financing USD 3 2013–2017 UNAIDS Global AIDS Monitoring expenditure database $2k (2017)
PEPFAR expenditure, HHS/CDC Financing USD 5 2021–2025 PEPFAR budgets and expenditure $37.2m (2025)
PEPFAR expenditure, USAID Financing USD 5 2021–2025 PEPFAR budgets and expenditure $32.8m (2025)
PEPFAR expenditure, all US agencies Financing USD 14 2013–2025 PEPFAR budgets and expenditure, PEPFAR operating-unit budgets, UNAIDS Global AIDS Monitoring expenditure database $73.6m (2025)
PEPFAR expenditure, other US agencies Financing USD 5 2021–2025 PEPFAR budgets and expenditure $3.6m (2025)
PEPFAR planned commodity procurement, like for like Financing USD 7 2019–2025 PEPFAR commodity procurement plans $20.8m (2025)
PEPFAR planned funding (budget), all US agencies Financing USD 19 2007–2025 PEPFAR budgets and expenditure, PEPFAR operating-unit budgets $105.0m (2025)
PEPFAR planned funding, HHS/CDC Financing USD 5 2021–2025 PEPFAR budgets and expenditure $41.8m (2025)
PEPFAR planned funding, USAID Financing USD 5 2021–2025 PEPFAR budgets and expenditure $56.5m (2025)
PEPFAR planned funding, other US agencies Financing USD 5 2021–2025 PEPFAR budgets and expenditure $6.8m (2025)
PEPFAR planned procurement of antiretroviral drugs Financing USD 7 2019–2025 PEPFAR commodity procurement plans $10.2m (2025)
PEPFAR planned procurement of laboratory commodities Financing USD 7 2019–2025 PEPFAR commodity procurement plans $5.6m (2025)
PEPFAR planned procurement of rapid test kits Financing USD 7 2019–2025 PEPFAR commodity procurement plans $2.1m (2025)
PEPFAR spend on staff, human resources for health inventory Financing USD 1 2025 PEPFAR human resources for health inventory $21.3m (2025)
PEPFAR-funded staff delivering services, full-time equivalents Financing count 1 2025 PEPFAR human resources for health inventory 2,106 (2025)
PEPFAR-funded staff, full-time equivalents Financing count 1 2025 PEPFAR human resources for health inventory 3,140 (2025)
Private HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $2.9m (2023)
Private HIV expenditure (country-reported) Financing USD 10 2013–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $14.9m (2021)
US HIV disbursements managed by Health and Human Services Financing USD 24 2003–2026 ForeignAssistance.gov $9.7m (2026)
US HIV disbursements managed by USAID Financing USD 24 2003–2026 ForeignAssistance.gov $6k (2026)
US HIV disbursements managed by other US agencies Financing USD 21 2006–2026 ForeignAssistance.gov $45k (2026)
US HIV disbursements managed by the State Department Financing USD 18 2008–2026 ForeignAssistance.gov $14.5m (2026)
USAID funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $6.7m (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 3 2021–2022 UNAIDS AIDSinfo, WHO Global Health Observatory 60.0% (2022)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 66 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 71.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 73.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 22 2002–2024 UNAIDS AIDSinfo 48.3% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 1 2018 UNAIDS AIDSinfo 37.0% (2018)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 9 2014–2024 UNAIDS AIDSinfo 8.8% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 6 2018–2024 UNAIDS AIDSinfo 51.7% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 29 2017–2025 PEPFAR results by province, WHO Global Health Observatory 90.0% (2022)
% of returned HIV test results that were positive Treatment cascade percent 20 2019–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 2.1% (2024)
HIV tests performed at a health facility Treatment cascade count 12 2018–2025 PEPFAR testing by modality, WHO HIV testing services dashboard 178,761 (2025)
HIV tests performed through community outreach Treatment cascade count 9 2018–2025 PEPFAR testing by modality, WHO HIV testing services dashboard 14,992 (2025)
HIV tests performed with the result returned to the person Treatment cascade count 70 2016–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 193,753 (2025)
HIV-exposed infants tested within two months of birth Treatment cascade percent 14 2010–2024 UNAIDS AIDSinfo 10.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 8,923 (2025)
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 1 2020 UNAIDS AIDSinfo 19.0% (2020)
Newly diagnosed at HHS/CDC-funded partners (MER HTS_TST_POS) Treatment cascade count 24 2018–2025 PEPFAR results by funding agency, PEPFAR results by funding agency and province 1,971 (2025)
Newly diagnosed at USAID-funded partners (MER HTS_TST_POS) Treatment cascade count 32 2018–2025 PEPFAR results by funding agency, PEPFAR results by funding agency and province 2,926 (2025)
Newly enrolled on ART at HHS/CDC-funded partners (MER TX_NEW) Treatment cascade count 24 2018–2025 PEPFAR results by funding agency, PEPFAR results by funding agency and province 1,917 (2025)
Newly enrolled on ART at USAID-funded partners (MER TX_NEW) Treatment cascade count 32 2018–2025 PEPFAR results by funding agency, PEPFAR results by funding agency and province 2,722 (2025)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS) Treatment cascade count 50 2016–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality 4,897 (2025)
Number of PLHIV virally suppressed (VL<1000) Treatment cascade count 35 2017–2025 PEPFAR Panorama Spotlight, PEPFAR results by province 100,858 (2025)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 117 2000–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo, WHO Global Health Observatory 407,600 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 43.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 3 2017–2025 Global Fund Data Service 36,164 (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 8 2018–2025 Global Fund Data Service 20,152 (2025)
People newly diagnosed at a health facility Treatment cascade count 8 2018–2025 PEPFAR testing by modality 4,328 (2025)
People newly diagnosed through community outreach Treatment cascade count 8 2018–2025 PEPFAR testing by modality 569 (2025)
People newly enrolled on ART during the year Treatment cascade count 51 2014–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, WHO Global Tuberculosis Programme 4,639 (2025)
People on ART at HHS/CDC-funded partners (MER TX_CURR) Treatment cascade count 24 2018–2025 PEPFAR results by funding agency, PEPFAR results by funding agency and province 82,757 (2025)
People on ART at USAID-funded partners (MER TX_CURR) Treatment cascade count 32 2018–2025 PEPFAR results by funding agency, PEPFAR results by funding agency and province 75,305 (2025)
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 102 2007–2023 Demographic and Health Surveys By population group, sex or age only, to 2023
People who completed a course of TB preventive therapy Treatment cascade count 8 2018–2025 PEPFAR Panorama Spotlight 8,139 (2025)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 9 2016–2024 UNAIDS AIDSinfo 36.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 48 2010–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, UNAIDS AIDSinfo, WHO Global Health Observatory 12,034 (2025)
TB patients recorded as HIV-positive Treatment cascade count 18 2015–2025 PEPFAR Panorama Spotlight, WHO Global Tuberculosis Programme 690 (2025)
TB patients with an HIV test result recorded Treatment cascade count 27 2015–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, WHO Global Tuberculosis Programme 9,361 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 13,000 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 6,900 (2024)
HIV prevalence among a key population Epidemic estimates percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 131 2000–2024 Demographic and Health Surveys, UNAIDS AIDSinfo, World Bank Open Data 0.7% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 23,000 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 23,000 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 570,000 (2025)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 102 2007–2023 Demographic and Health Surveys By population group, sex or age only, to 2023
Key-population members reached by prevention programmes Prevention and outreach percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Male condoms distributed in a year Prevention and outreach count 4 2020–2024 UNAIDS AIDSinfo 3,364,876 (2024)
People receiving PrEP Prevention and outreach count 30 2018–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo 8,194 (2025)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 54 2007–2023 Demographic and Health Surveys By population group, sex or age only, to 2023
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 28,000 (2025)
Estimated size of a key population Population denominators count 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 112,832,473 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 25.7% (2025)

Every row shown on the DR Congo page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.